A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, and is now set to move into larger trials that are likely to be decisive…
GlaxoSmithKline Plc and Sanofi, partners developing a potential coronavirus vaccine, are discussing a 500 million pound ($620 million) deal to supply the U.K. government with the shot, assuming it’s successful, said a…
South Africa will begin a coronavirus vaccine trial on Wednesday, the first such test on the continent, with its 2,000 volunteers planned to include some living with HIV. The trial…
Recent Comments